SKGEL® Implant Versus T-Flux® Implant in the Contralateral Eye in Deep Sclerectomy with Phacoemulsification: Long-Term Follow-Up

Abstract

PURPOSE: To intraindividually compare the efficacy and safety of the SKGEL((R)) implant versus the T-Flux((R)) implant in deep sclerectomy. METHODS: In a retrospective analysis 17 patients were identified who underwent combined phacoemulsification-deep sclerectomy and implantation of SKGEL((R)) in one eye and T-Flux((R)) in the contralateral eye. RESULTS: In eyes with SKGEL((R)) the IOP decreased from 20.6+7.3 mm Hg to 14.8+5.3 mm Hg (-5.8 mm Hg or -28.1%), and in eyes with T-Flux((R)) from 19.9+7.2 mm Hg to 14.7+3.3 mm Hg (-5.2 mm Hg or -26.1%, no statistically significant difference, p >0.05). Antiglaucoma medications with either implant decreased from initially 2.0+0.8 to 0.3+0.7. A qualified success was found in 17/17 eyes with T-Flux((R)) and in 16/17 eyes with SKGEL((R)). Complete success was achieved in 14/17 eyes with T-Flux((R)) and in 13/17 eyes with SKGEL((R)). CONCLUSIONS: The IOP-lowering effect and safety of SKGEL((R)) and T-Flux((R)) seem to be comparable.